Published in Dig Dis Sci on July 03, 2015
ADPKD Alterations in Hepatic Transporter Function | NCT03717883
Non-alcoholic fatty liver disease and diabetes. Metabolism (2016) 0.82
Nuclear receptors and nonalcoholic fatty liver disease. Biochim Biophys Acta (2016) 0.81
Metabonomics Research Progress on Liver Diseases. Can J Gastroenterol Hepatol (2017) 0.77
Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling. Am J Physiol Gastrointest Liver Physiol (2016) 0.77
Key Role for the 12-Hydroxy Group in the Negative Ion Fragmentation of Unconjugated C24 Bile Acids. Anal Chem (2016) 0.77
Circadian clock control of hepatic lipid metabolism: role of small heterodimer partner (Shp). J Investig Med (2016) 0.76
Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease. PLoS One (2016) 0.76
Developmental origins of NAFLD: a womb with a clue. Nat Rev Gastroenterol Hepatol (2016) 0.76
Obesity diabetes and the role of bile acids in metabolism. J Transl Int Med (2016) 0.75
Is Moderate Alcohol Use in Non-Alcoholic Fatty Liver Disease Good or Bad? A Critical Review. Hepatology (2017) 0.75
Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis. Prostaglandins Other Lipid Mediat (2016) 0.75
Liver Cholesterol Overload Aggravates Obstructive Cholestasis by Inducing Oxidative Stress and Premature Death in Mice. Oxid Med Cell Longev (2016) 0.75
Gut Microbiota and Complications of Liver Disease. Gastroenterol Clin North Am (2017) 0.75
Effect of Liver Disease on Hepatic Transporter Expression and Function. J Pharm Sci (2017) 0.75
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology (2004) 18.86
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature (2006) 9.36
TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab (2009) 6.91
The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem (2003) 6.35
Bile salt biotransformations by human intestinal bacteria. J Lipid Res (2005) 6.00
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology (2012) 5.47
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A (2006) 3.05
Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol (2012) 2.89
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastroenterology (2013) 2.70
Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res (2005) 2.64
Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology (2012) 2.62
Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest (1999) 2.32
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer (2007) 2.23
A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest (1998) 2.16
Bile-acid-induced cell injury and protection. World J Gastroenterol (2009) 2.06
Interactions between the intestinal microbiome and liver diseases. Gastroenterology (2014) 1.92
Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology (2013) 1.84
Bile Acids: The Good, the Bad, and the Ugly. News Physiol Sci (1999) 1.81
Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis. Hepatology (2013) 1.78
Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism (2010) 1.77
Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta (2010) 1.66
Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med (1998) 1.55
Promoting effect of sodium deoxycholate on colon adenocarcinomas in germfree rats. J Natl Cancer Inst (1976) 1.52
Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J Clin Invest (1993) 1.46
Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer (2007) 1.28
Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease. Drug Metab Dispos (2011) 1.24
Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting. PLoS One (2011) 1.15
Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method. J Lipid Res (2012) 1.10
Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study. Dig Liver Dis (2011) 1.09
FXR and PXR: potential therapeutic targets in cholestasis. J Steroid Biochem Mol Biol (2011) 1.08
Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease. Toxicol Appl Pharmacol (2013) 1.08
Bile acid levels are increased in the liver of patients with steatohepatitis. Eur J Gastroenterol Hepatol (2008) 1.06
Gallbladder emptying stimuli in obese and normal-weight subjects. Hepatology (1992) 0.99
The relationship between postprandial bile acid concentration, GLP-1, PYY and ghrelin. Clin Endocrinol (Oxf) (2011) 0.94
Colonic inflammation and secondary bile acids in alcoholic cirrhosis. Am J Physiol Gastrointest Liver Physiol (2014) 0.92
Alcoholic and non-alcoholic steatohepatitis. Exp Mol Pathol (2014) 0.89
Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis. Clin Pharmacol Ther (2015) 0.86
Profiling of serum bile acids in a healthy Chinese population using UPLC-MS/MS. J Proteome Res (2015) 0.85
Dysregulated bile acid synthesis, metabolism and excretion in a high fat-cholesterol diet-induced fibrotic steatohepatitis in rats. Dig Dis Sci (2013) 0.81